Six Hires for Prescription Decisions Specialist RxY

RxY, a division of healthcare researcher P\S\L Group focused on understanding physicians' prescribing decisions across global markets, has recently welcomed Dana Gheorge, Sahiba Dilbaghi, Aditya Choksi and Breanna Hudspeth to its Research team, and John Dang and Osato Agbontaen to its sales team.

RxY is a sister company to fieldwork specialist Medefield, and promises to help clients the 'true why / why not' behind physician treatment choices, combining rich qual data with large sample quant to fill the gaps it says are left by quant-only research.

Gheorge and Dilbaghi join as Research Directors, focusing on Oncology and CardioMetabolic, respectively; while Choksi takes the role of Senior Research Manager, Neuroscience and Hudspeth Research Manager, Dermatology. Dang and Agbontaen join as Sales Directors, respectively for the USA and Europe.

RxY reports continued double-digit growth, and says the hires mean it is expanding its capabilities and strengthening its expertise to better serve clients. Global MD Paul O'Shaughnessy comments: 'At RxY, our mission is clear: to help brand teams grow patient share. These strategic hires bring deep therapeutic expertise and client insight that will further strengthen our ability to deliver high-impact research across all stages of the brand lifecycle.'

The firm is online at www.rxyhc.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.